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Abstract
Cytochrome c (Cytc) is essential in mitochondrial electron transport and intrinsic type II
apoptosis. Mammalian Cytc also scavenges reactive oxygen species (ROS) under healthy
conditions, produces ROS with the co-factor p66Shc, and oxidizes cardiolipin during apoptosis.
The recent finding that Cytc is phosphorylated in vivo underpins a model for the pivotal role of
Cytc regulation in making life and death decisions. An apoptotic sequence of events is proposed
involving changes in Cytc phosphorylation, increased ROS via increased mitochondrial membrane
potentials or the p66Shc pathway, the oxidation of cardiolipin by Cytc, and its release from the
mitochondria. Cytc regulation in respiration and cell death is discussed in a human disease context
including neurodegenerative and cardiovascular diseases, cancer, and sepsis.
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1. Introduction
Mitochondria are unique cellular organelles that possess their own DNA, encoding thirteen
subunits of the respiratory complexes in mammals as well as twenty-two tRNAs and two
rRNAs (Chan, 2006). Mitochondria are the site of the citric acid cycle and utilize the
substrates from this process to drive the electron transport chain (ETC) and the production
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of cellular energy in the form of adenosine triphosphate (ATP). As the main (>90%)
producers of ATP, mitochondria satisfy the energy requirements of the entire cell.
Mitochondria serve a vital function by maintaining a balance of cellular homeostasis which
is not limited to energy level maintenance, but includes such diverse factors as calcium and
reactive oxygen species (ROS) (Jezek and Hlavata, 2005; Lee and Tse, 2005; Samavati et
al., 2008; Wang et al., 2003a). The balance between ROS and ATP production is preserved
by integrating multiple cellular signals. When the equilibrium is shifted towards ROS
production, major disturbances in cell function and viability occur. Such perturbations are
seen in an increasing number of human diseases including such diverse conditions as
neurodegenerative diseases, diabetes, cancer, and sepsis (Duvigneau et al., 2008; Kadenbach
et al., 2004b; Samavati et al., 2008; Sheehan et al., 1997). In addition, mitochondria play a
key role in aging, which is accompanied by decreased mitochondrial capacity to produce
ATP and accumulation of damaged mitochondria over time, including mtDNA mutations
(reviewed in Mammucari and Rizzuto, 2010). The ETC produces the majority of cellular
ROS, and it has been estimated that up to 1-2% of oxygen consumed can be converted into
superoxide anions (O2•–) (Richter et al., 1988). Consequently, the underlying processes that
dictate the cell's fate are important for cellular development and maintenance and must be
tightly regulated in order to ensure overall tissue and organism health. When stress signals
outweigh the benefits of sustaining viability, various signals can initiate the programmed
cell death process through intrinsic (mitochondrial) type II apoptosis. These two seemingly
contradictory functions, i.e., life-sustaining energy production and apoptosis, converge on
cytochrome c (Cytc).
Cytc is an evolutionarily conserved nuclear-encoded mitochondrial protein, which contains
104 amino acids in mammals. It is highly positively charged with a pI of 9.6. Cytc is
essential for aerobic energy production and Cytc knockout mice die around midgestation (Li
et al., 2000a). Until that developmental stage energy production relies only on 5% aerobic
metabolism, then switches to aerobic energy metabolism relying 95% on OxPhos after
gestation day 11 (Morriss and New, 1979).
Cytc is a multi-functional enzyme that is involved in life and death decisions of the cell (Fig.
1). It participates in electron transfer as part of the mitochondrial electron transport chain
(ETC) and is thus an indispensable part of the energy production process. It is also essential
for the formation of the apoptosome and the progression of apoptosis. Recent discoveries of
additional functions of Cytc, including its activity as a cardiolipin peroxidase (Kagan et al.,
2004;Kagan et al., 2005), and the detection of four phosphorylation sites on Cytc (Lee et al.,
2006;Yu et al., 2008;Zhao et al., 2010), suggest that its multiple functions are regulated by
cell signaling pathways. Derivation of the specific pathways that operate these regulatory
mechanisms and their effects may become an important avenue for therapeutic targeting of
various human illnesses including neurodegenerative diseases, congestive heart failure, and
cancer. Below, we first discuss the diverse functions of Cytc and conclude with a model that
proposes regulation of Cytc via phosphorylation as the central mechanism integrating and
regulating the functions of Cytc.
2. Structure of cytochrome c
Cytc was one of the first mammalian proteins subjected to X-ray crystallography, and the
first 4Å resolution structure was obtained from oxidized horse heart Cytc in the late sixties
(Dickerson et al., 1967). Higher resolution structures of Cytc from horse (Bushnell et al.,
1990) and other organisms were subsequently published allowing a more detailed view of its
basic properties (Fig. 2). The heme group is covalently linked to the Cytc peptide chain
through thioether bonds with cysteine residues 14 and 17 (amino acid numbering is based on
the mature peptide, which lacks the N-terminal methionine, Fig. 3). The heme iron is in a
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hexacoordinate configuration with His18 and Met80 as amino acid ligands (Fig. 2). The
heme iron-Met80 bond causes the weak 695 nm absorption band in the spectrum of Cytc in
the oxidized state. The presence of aliphatic and aromatic amino acid side chains places the
heme group in a very hydrophobic environment, which together with the iron ligands His18
and Met80 was proposed to explain the high redox potential of Cytc of about 260 mV in
mammals (Salemme, 1977). Of the entire heme surface only 7.5% are solvent-exposed as
part of the frontal edge of the heme group (Bushnell et al., 1990). This is the site used to
transfer electrons from bc1 complex to cytochrome c oxidase (CcO), which was confirmed
by co-crystallization of Cytc with bc1 complex from yeast (Lange and Hunte, 2002) and
computer prediction of the Cytc-CcO complex based on the bovine CcO crystal structure
(Roberts and Pique, 1999).
3. Role of cytochrome c in oxidative phosphorylation
ATP generation is the purpose of the oxidative phosphorylation (OxPhos) machinery, which
is housed in the inner mitochondrial membrane and consists of the electron transport chain
(ETC) and ATP synthase. Oxidative phosphorylation is fueled by several substrates that feed
electrons into the ETC, including NADH and FADH2. While transferring these electrons,
the ETC generates the mitochondrial membrane potential (ΔΨm). ETC complexes I (NADH
dehydrogenase), III (bc1 complex), and IV (cytochrome c oxidase, CcO) pump protons from
the matrix into the intermembrane space. The mitochondrial membrane potential is utilized
by ATP synthase (complex V) to drive its operation in the final step, the production of ATP.
ATP synthase is a rotary nano motor converting the membrane potential into rotational and
chemical energy by combining a phosphate and an ADP molecule into ATP (Stock et al.,
1999).
Cytc is located in the mitochondrial intermembrane space and functions as a single electron
carrier from the bc1 complex to CcO in the final step of the ETC. In this step reduced Cytc
transfers an electron to CcO and four such electron transfers are required to reduce an
oxygen molecule to water. In intact mammalian cells this reaction is the proposed rate-
limiting step of the ETC under physiological conditions (Acin-Perez et al., 2003; Dalmonte
et al., 2009; Piccoli et al., 2006; Villani and Attardi, 1997; Villani et al., 1998). The electron
transfer reaction from Cytc to oxygen via CcO leads to the conversion of oxygen to water
with a free energy of ΔGo’= -100 kJ/mol, which is about twice as high compared to the
reactions catalyzed by complexes I and III (Hinkle et al., 1991). Since this is an essentially
irreversible reaction, we and others have proposed that this step of the ETC should be tightly
regulated. This hypothesis is supported by the fact that all major regulatory mechanisms are
present, including allosteric regulation of CcO and Cytc (e.g., by the ATP/ADP ratio), the
expression of tissue-specific isoforms of Cytc and six subunits of CcO, and reversible post-
translational modifications, in particular phosphorylations, which have been identified in all
mammalian OxPhos components (for reviews see Hüttemann et al., 2007; Hüttemann et al.,
2008).
4. Cytochrome c and Erv1-Mia40-coupled protein import
Since the majority of mitochondrial proteins are nuclear encoded, their transport into
mitochondria is a crucial process. This is mainly accomplished through the work of
translocases of the inner and outer membranes, TIMs and TOMs, respectively (Rehling et
al., 2001). Import of the precursor proteins is followed by additional folding and/or
assembly into functional proteins. Often this involves enzymes to assist in converting a
protein from its apo- to holo-form as in the case of Cytc import.
Cytc is imported into mitochondria as apocytochrome c, a process that is independent of the
mitochondrial membrane potential, ATP, or the Mia40-dependent pathway involving
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TOM40 (Diekert et al., 2001). The holo-form of Cytc is formed by heme addition, catalyzed
by the enzyme Cytc heme lyase, which is also known as holocytochrome-c synthase
(Dumont et al., 1991).
Cytc is involved in redox-coupled import of proteins containing twin CX3C and CX9C
motifs into the mitochondrial intermembrane space in connection with the proteins Erv1 and
Mia40. Small TIMs represent a prominent group of proteins imported into the mitochondria
via this pathway (reviewed in Riemer et al., 2010). This import occurs via TOMs and
similarly requires post-import modification, i.e., alternative folding introduced via the
creation of disulfide bonds between cysteine residues. These reactions are dependent upon
oxidoreductase systems. Specifically, the import and assembly of TIMs has been shown to
be contingent upon Mia40 oxidation of the imported protein and the formation of disulfide
bonds that alter the protein's tertiary structure (Chacinska et al., 2004). Reactivation of the
Mia40 protein subsequently relies on oxidation by Erv1, which is dependent upon the
activity of Cytc for its re-oxidation (Allen et al., 2005). This mechanism of import and
cascade of redox reactions provides a route for the transfer of electrons from the Mia40
import pathway to Cytc and thus into the ETC.
5. Regulation of cytochrome c and cytochrome c oxidase by adenine
nucleotides
Anions in general have been demonstrated to affect the physical interaction between Cytc
and CcO, but ATP is particularly noteworthy. ATP, the end product of OxPhos, regulates
the rate of electron transport as a feedback inhibitor of the interaction between Cytc and
CcO through binding to both proteins (Arnold and Kadenbach, 1999; Ferguson-Miller et al.,
1976; Napiwotzki et al., 1997). The allosteric inhibition exhibited by ATP has been shown
to act in an uncompetitive manner, altering the high-affinity Cytc-CcO binding site to a low-
affinity site (Ferguson-Miller et al., 1976). Arg91 has been identified as the key amino acid
of Cytc involved in the binding of ATP. When this site is occupied by ATP, electron-
transfer activity of Cytc is significantly downregulated (Craig and Wallace, 1995; Tuominen
et al., 2001). Presumably this effect is due to structural changes of both proteins as well as
electrostatic changes when negatively charged ATP binds to Cytc and CcO. As a result,
ETC activity is adjusted to energy demand through the ATP/ADP ratio as an intrinsic
measure of the energetic state of the cell. However, it should be noted that the
phosphorylation state of CcO (and perhaps also Cytc) plays an overarching role by enabling
allosteric regulation, because after in vitro dephosphorylation of cow liver CcO no inhibitory
effect of ATP was detectable (Hüttemann et al., 2008). Therefore, allosteric regulation
should be considered in conjunction with the phosphorylation state of CcO and Cytc.
6. Regulation of cytochrome c through tyrosine phosphorylation
Cell signaling targeting the mitochondrial OxPhos proteins is a new research area. It may
transform the traditional thinking about the regulation of OxPhos, which is mainly derived
from studies in bacteria (see also section 9). More than 20 phosphorylation sites have been
mapped on mammalian OxPhos proteins (Hüttemann et al., 2007). However, for most of
them the corresponding signaling pathways as well as kinases and phosphatases remain
unknown or unclear. Tyrosine phosphorylation is very specific and mainly found in higher
organisms. It is this regulatory mechanism that affects Cytc in a distinct tissue-specific
manner.
In the past, commonly used isolation methods of Cytc have not taken into account the
possibility of Cytc phosphorylation in vivo. The result has been isolation of
dephosphorylated protein, including those available from commercial sources, and therefore
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its potential as an integral target of cellular signaling was overlooked. In order to preserve in
vivo phosphorylation, our isolation methods include the use of nonspecific phosphatase
inhibitors, fluoride and vanadate.
Preserving the physiological in vivo phosphorylation state, we isolated Cytc from cow heart
and liver tissue without manipulating cell signaling pathways. Western analysis with an anti-
phosphoSer/Thr/Tyr antibodies indicated tyrosine phosphorylation in both experiments.
Interestingly, mass spectrometry unambiguously revealed that the phosphorylated residues
were distinct, suggesting that cell signaling targets Cytc in a tissue-specific manner. Cytc
isolated from cow heart was phosphorylated on Tyr97 (Lee et al., 2006), whereas cow liver
Cytc revealed phosphorylation on Tyr48 (Fig. 2) (Yu et al., 2008). Both tyrosines are highly
conserved among eukaryotes (Fig. 3), suggesting their potential importance as targets of cell
signaling pathways.
Spectral analysis of oxidized Cytc shows a weak but specific 695 nm absorption band which
is the result of the Met80-heme iron bond. This band was called an “indicator of trouble”
because its absence implies a dysfunctional and denatured conformation of Cytc (Dickerson
and Timkovich, 1975). Tyr97- but not Tyr48-phosphorylated Cytc showed a shift of the 695
nm absorption band to 687 nm suggesting that Tyr97-phosphorylation influences the heme
environment despite being localized to the periphery of the molecule (Fig. 2) (Lee et al.,
2006).
Both tyrosine phosphorylations lead to an inhibition in the reaction with isolated CcO.
Tyr97-phosphorylated Cytc showed enhanced sigmoidal kinetics in the reaction with CcO,
and half-maximal turnover was observed at a Cytc substrate concentration of 5.5 μM
compared to 2.5 μM for unphosphorylated Cytc (Lee et al., 2006). For Tyr48-
phosphorylated Cytc the kinetics were hyperbolic, similar to unphosphorylated Cytc.
However, maximal turnover was more than 50% reduced for the phosphorylated form (Yu et
al., 2008). These observations of partial inhibition of mitochondrial respiration as a
consequence of Cytc phosphorylation fits our model that under healthy conditions
mammalian OxPhos runs at reduced activity (‘controlled state,’ Fig. 4) to avoid high
mitochondrial membrane potentials, which are known to lead to excessive ROS production,
a hypothesis that we will revisit in section 9. The effects of tyrosine phosphorylation on the
other functions of Cytc, as far as they are known, are discussed below.
Two additional phosphorylation sites on Cytc have recently been reported. Mitochondria
isolation from human skeletal muscle followed by high throughput phospho-proteomic
mass-spectroscopy analysis revealed phosphorylation of Thr28 and Ser47 on Cytc (Figs. 2
and 3) (Zhao et al., 2010), suggesting that Cytc in this tissue is targeted for phosphorylation
by yet another signaling pathway. The extent of those phosphorylations, i.e., the ratio of
phosphorylated versus unphosphorylated Cytc, and their functional consequences remain
unknown.
7. The Good, the Bad and the Ugly – reactive oxygen species and the role
of cytochrome c as a radical scavenger and producer
The most common reactive oxygen species include superoxide (O2• –), hydrogen peroxide
(H2O2), and hydroxyl radicals (•OH). The term reactive oxygen species (ROS) applies to
any of the numerous oxygen containing molecules that have a strong propensity to fill their
outer orbital shells by extracting an electron from an alternate source (e.g., the “free
radical” •OH) or because – in the presence of transition metals – they are unstable molecules
(e.g., H2O2, which is not a free radical). These molecules are highly reactive and if given the
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opportunity will damage DNA and other cellular structures. They also initiate oxidation
cascades that regenerate radical species and perpetuate their damage.
ROS are generated in mitochondria as a direct result of the very nature of the electron
transport chain. The electron transfer reactions that occur at the ETC complexes expose the
redox intermediates to side reactions that can result in transfer of electrons directly to
oxygen (Cadenas and Davies, 2000; Kadenbach et al., 2004b). The main ROS production
sites are complex I, complex III, and the reduced ubiquinol pool. Complex I generates and
releases ROS on the matrix site whereas complex III can release ROS into the matrix and
the intermembrane space (Han et al., 2003; Han et al., 2001; Turrens et al., 1985). These
side reactions cause cellular damage, and a buildup of ROS, if unregulated, will result in
apoptosis (Aoki et al., 2002).
7.1. Cytochrome c as a ROS scavenger
Since ROS are unavoidable, cells have developed a battery of tools to neutralize these
threats. These radical scavengers function as enzymes and are therefore restricted by their
kinetic reaction rates. Superoxide dismutase (SOD) reduces superoxide molecules to
hydrogen peroxide that is subsequently detoxified by catalase. However, ROS such as
hydroxyl radicals are much too reactive to be effectively neutralized by an enzymatic
pathway due to a half-life of only about one nanosecond. In contrast superoxide can be
neutralized due to a half-life of about one millisecond.
It was shown that free Cytc also functions as a radical scavenger within the inner-membrane
space by removing unpaired electrons from superoxide thus regenerating O2 (Korshunov et
al., 1999; Pereverzev et al., 2003). The extracted electron can subsequently be used in
energy production via transfer to CcO, thereby regenerating the oxidized form of Cytc. In
addition, it was demonstrated that Cytc operates as a hydrogen peroxide scavenger (Wang et
al., 2003c). In contrast to neutralization of superoxide, which requires oxidized Cytc,
conversion of hydrogen peroxide will be effective in both reduced and oxidized states of
Cytc. Since Cytc constantly undergoes oxidation/reduction cycles in a respiring cell, both
detoxification reactions can take place. Therefore, coupling of ROS neutralization with the
redox capabilities of Cytc makes the latter an ideal antioxidant for the cell.
7.2. Cytochrome c and p66shc
p66shc is a splice variant of the growth factor adapter Shc and found throughout the cell with
a subset localizing to the mitochondria where it affects mitochondrial function (Nemoto et
al., 2006). p66shc is regulated via reversible phosphorylation which involves the protein
kinase Cβ pathway (Pinton et al., 2007). Downstream phosphorylation of Ser36 appears to
be an essential regulator of p66shc function and phosphorylation of this site increases with
age in several organs including lung, liver, and skin, leading to higher ROS production rates
and accumulation of oxidative damage as was demonstrated in aged mice (Lebiedzinska et
al., 2009). Under stress conditions, mitochondrial p66shc oxidizes, i.e., receives electrons
from Cytc and subsequently produces hydrogen peroxide (Giorgio et al., 2005). This
pathway represents a means of ROS production which can be regulated.
Cell lines null for p66shc have lower levels of ROS (Nemoto and Finkel, 2002) and
decreased oxygen consumption rates compared to wild-type cells, and transfection with a
p66shc expression vector restored normal levels of oxygen consumption (Nemoto et al.,
2006). p66shc null cells also show a decreased response to oxidative damage after treatment
with H2O2 or UV light (Migliaccio et al., 1999). Treatment with X-rays resulted in cell-
proliferation arrest in both wild-type and null cell lines, suggesting that the p66shc protein
functions specifically in the apoptotic response to oxidative damage (Migliaccio et al.,
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1999). p66shc null cells also have slower metabolic rates and switch to glycolytic ATP
production, which is accompanied by decreased ROS generation (Nemoto et al., 2006). The
decrease in oxidative stress, coupled with a disruption of the cellular response to oxidative
stress, results in an almost 30% increase in lifespan of p66shc null mice (Migliaccio et al.,
1999).
The increase in ROS production via p66shc as part of the apoptotic pathway would provide
Cytc with peroxide equivalents necessary for the oxidation of cardiolipin, a process that is
required for its release from the mitochondria as discussed below. Indeed, release of Cytc
correlates with the H2O2 production activity of p66shc (Sun et al., 2010). This – along with
inability of Cytc/cardiolipin complexes to accept electrons from complex III (Basova et al.,
2007) – could be a significant switch utilized by the cell as an initiating event of apoptosis.
The possible role of Cytc phosphorylation as an independent regulator of the interplay
between Cytc and p66shc is currently unknown. However, given its effect on downstream
caspase activation (see section 8) one might speculate that Cytc phosphorylation provides an
additional safeguard mechanism to regulate ROS production independent of Ser36
phosphorylation of p66shc (Fig. 4).
7.3. Testis-specific cytochrome c: an isoform with superior ROS scavenging properties
A unique isoform of Cytc was first identified in the testicular cells of rodents. This testis-
specific isoform of Cytc (T-Cytc) is expressed in the germinal epithelial cells (Goldberg et
al., 1977). Although the amino acid sequence of T-Cytc is 86% homologous to somatic Cytc
(S-Cytc or simply Cytc; Fig. 3), its expression pattern and biological functions are distinct.
S-Cytc is expressed in all cells including those of the testis, however its expression is
gradually decreased in the testicular germ cells. As spermatogenesis proceeds, T-Cytc
expression increases, becoming the predominant form in mature sperm (Goldberg et al.,
1977; Hess et al., 1993; Liu et al., 2006). T-Cytc operates with a three-fold increased H2O2
reduction activity; however, at the same time its apoptotic activity is also significantly
increased (about fourfold compared to S-Cytc) (Liu et al., 2006). The authors concluded that
these effects help prevent radical damage of sperm and serve as a selective agent by
initiating cellular death of dysfunctional or damaged sperm. These functions are of particular
importance in testes where the integrity of sperm must be highly regulated in order to ensure
efficient and complete DNA transmission.
Interestingly, a cell line derived from Cytc knockout mice is respiratory-competent due to
induction and expression of the testes isoform (Vempati et al., 2007). Furthermore, the
authors showed that T-Cytc was able to promote apoptosis through both the intrinsic and
extrinsic pathway, suggesting that both death pathways converge at Cytc.
The testis isoform of Cytc was lost during primate evolution, and it is now a non-transcribed
pseudogene in humans (Hüttemann et al., 2003; Zhang and Gerstein, 2003). Consequently,
human Cytc has to exercise both testis- and non-testis-specific functions using the same
basic molecule. It is therefore not surprising that Cytc underwent some evolutionary changes
in the lineage leading to humans, which is also reflected in an altered Cytc-CcO binding
epitope (Schmidt et al., 2005). Human Cytc shares more homology with mouse Cytc-S (91%
identity) compared to Cytc-T (82% identity) (Fig. 3). Among the 20 sites that are variable in
the alignment of the three sequences, in humans 11 of those correspond to the somatic and
only 2 sites correspond to the testis isoform in mouse (Fig. 3).
Hüttemann et al. Page 7
Mitochondrion. Author manuscript; available in PMC 2012 May 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
8. Role of cytochrome c in apoptosis
8.1. Cytochrome c release is an essential step in the apoptotic cascade
The importance of Cytc during development and life is not restricted to its involvement in
ATP production and as a radical scavenger, but extends to its essential role in apoptosis. The
first report showing that Cytc plays a crucial role in the cell death pathway was published in
1996 using a cell free apoptotic system to which compounds can be added, such as Cytc and
dATP, another factor required for induction of the program (Liu et al., 1996). Other early
work suggested that molecular changes at the level of Cytc, but not its degradation, occurred
during the course of apoptosis (Krippner et al., 1996). Since then thousands of studies have
been published confirming and extending those initial findings. It is now generally accepted
that a key step in the apoptotic cascade involves the release of Cytc into the cytosol where it
binds with apoptotic protease-activating factor 1 (Apaf-1). Binding of Cytc results in an
increased affinity of the complex for dATP whose binding is necessary for oligomerization
and formation of the apoptosome (Wang, 2001). The apoptosome recruits multiple
procaspase-9 molecules and promotes their cleavage to an active form, known as the
initiators of apoptosis. Caspase-9 bound to the apoptosome acts as the cleavage factor of
caspase-3, or what is considered the major enzyme in the committal to apoptosis (Green,
2000; Wang, 2001). Recently developed spectroscopic methods now allow the real-time
measurements of Cytc distribution in the cell based on changes in its redox state, when it is
released into the reducing cytosolic environment during apoptosis (Ripple et al., 2010).
Cell lines null for Cytc exhibit reduced caspase-3 activation when stimulated with apoptosis
inducing agents (Li et al., 2000a), indicating that Cytc is essential for caspase activation.
Therefore cells with Cytc deficiencies will not only have decreased metabolic rates, but also
will be resistant to stress signals that would typically induce cell death.
Other recent studies have suggested that Cytc release initiates apoptosis by binding inositol
trisphosphate (IP3) receptors, causing calcium release into the cytosol (Beresewicz et al.,
2006) and subsequent calpain activation and apoptosis-inducing factor (AIF) release (Cao et
al., 2007). Interestingly, it has long been known that isolated mitochondria can reversibly
release and take up Cytc, while the latter restores their function (Jacobs and Sanadi, 1960).
Cytc can be selectively released from the mitochondrial intermembrane space in a fashion
that does not necessarily involve membrane rupture or mitochondrial permeability transition
pore opening (Doran and Halestrap, 2000). Thus, Cytc release during apoptosis is not all-or-
none; instead a certain threshold of released Cytc must be reached before a cell irreversibly
commits to apoptosis (Clayton et al., 2005). The release of Cytc precedes permeability
transition (Chalmers and Nicholls, 2003) and is accompanied by a sharp increase in ROS
production that involves complex I (Kushnareva et al., 2002), thus elevated ROS could then
serve as an initiator for permeability transition.
An interesting and medically important example for the reversibility of Cytc release to
restore ETC activity was demonstrated in an animal model for sepsis. Sepsis is a systemic
inflammatory condition and it can lead to multiple organ failure and death. In a mouse
model for sepsis the authors found inhibition of oxidative phosphorylation at the level of
Cytc and CcO in the heart (Piel et al., 2008; Piel et al., 2007). The intravenous injection of
cow Cytc led to an uptake of Cytc into the cardiomyocytes and significantly improved
mitochondrial function, and survival increased from 15% for the controls to about 50% in
the septic mice that received the Cytc injections. At first sight these findings may seem
puzzling, because Cytc not only has to be taken up by the mitochondria, but it also has to
translocate across the cell membrane. Interestingly, it was recently shown that Cytc contains
cell penetrating peptide (CPP) epitopes in the N- and C-terminal helices (Jones et al., 2010).
Such CPPs can mediate the cellular uptake of proteins and may explain that intravenous
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injection of Cytc can restore ETC function in heart in vivo. However, yet another question
needs attention: why does the treatment with exogenous Cytc, which will be taken up into
the cytosol first, not amplify the apoptotic cascade but instead lead to increased survival of
the septic mice? Although no definite answer can be given at this point one can speculate
that the amino acid differences between cow Cytc, which was administered to the septic
mice, cause ineffective binding to mouse Apaf-1, insufficient to trigger caspase activation.
Small changes in Cytc are sufficient to render it incapable of triggering apoptosis. For
example, nitration of Tyr74 still allows Cytc to bind to Apaf-1 but the complex is unable to
activate downstream caspases (Garcia-Heredia et al. 2010). Alternatively, Cytc might
become phosphorylated by a serum kinase before entering the cells.
8.2. Regulation of cytochrome c release and apoptosome formation via cytochrome c
phosphorylation
Since the release of Cytc from the mitochondria and subsequent formation of the
apoptosome is the key step that controls the fate of the cell, one would expect it to be tightly
regulated, and we propose that this regulation involves phosphorylation of Cytc. We have
recently shown that cow liver Cytc is phosphorylated on Tyr48 in vivo (Yu et al., 2008).
Strikingly, mutant Cytc containing the negatively charged and thus phosphomimetic amino
acid Glu48 instead of Tyr48 was completely incapable of inducing downstream caspase
activation (Pecina et al., 2010), suggesting a switch for the regulation of apoptosis.
Critical protein-protein interactions involving Cytc and Apaf-1 occur in the cytosol, which
may be affected by Cytc phosphorylation. This binding involves several surface residues of
Cytc and results in Apaf-1 enveloping the molecule. A mutational analysis of Cytc has
identified several amino acids that are required for apoptosome formation and Lys7 is one of
them, without which binding affinity is greatly diminished (Yu et al., 2001). Lys7 is
spatially located next to Tyr97 (Fig. 2), which was shown to be phosphorylated in vivo in
cow heart (Lee et al., 2006). A phosphorylated Tyr97 might obstruct this binding via salt
bridge formation with Lys7 and prevent formation of the apoptosome, thus providing a
distinct means of regulating the apoptotic pathway in heart tissue where this phosphorylation
occurs, a hypothesis that we will test in future work.
8.3. Cytochrome c-catalyzed cardiolipin oxidation precedes cytochrome c release
Normally, about 15-20% of Cytc is bound to cardiolipin, a mitochondria-specific inner
membrane lipid (Schlame et al., 2000, Kagan et at., 2004). This fraction of hydrophobically
membrane-bound Cytc cannot be removed by treatment with high ionic strength solutions
(Belikova et al., 2006), and likely does not participate in electron transport due to a highly
negative redox potential. During apoptosis, trans-membrane migration of cardiolipin
facilitates its interactions with Cytc in the intermembrane space and the formation of Cytc/
cardiolipin complexes (Kagan et al, 2005). The free soluble pool of Cytc, which is re-
instated after cardiolipin peroxidation due to low affinity of Cytc for peroxidized cardiolipin
(Iverson and Orrenius, 2004, Kagan et al., 2005).
Cytc is bound to cardiolipin via two sites termed the A-site and C-site (Rytomaa and
Kinnunen, 1994) (Fig. 2). These two sites are distinct in that the A-site interaction is
predominantly of a loose electrostatic nature that participates in the electron transfer and
radical scavenging functions of Cytc. In contrast, the C-site utilizes hydrophobic interactions
and hydrogen bonding for a tight conformation associated with the oxidation of cardiolipin,
a Cytc-catalyzed reaction that occurs during the course of the apoptotic process as detailed
below. Cardiolipin oxidation is required for and thus precedes the release of Cytc from the
mitochondria (Kagan et al., 2009).
Hüttemann et al. Page 9
Mitochondrion. Author manuscript; available in PMC 2012 May 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
The binding of cardiolipin to the A-site of Cytc is reversible and easily displaced by ATP or
by increasing ionic strength (Rytomaa and Kinnunen, 1994; Rytomaa et al., 1992). The C-
site binding by Cytc is much more stable, and cardiolipin cannot be easily dissociated by
nucleotides (Rytomaa et al., 1992). The spectral changes observed with C-site binding
suggest the occurrence of conformational changes within the protein that affect the heme-
environment of Cytc (Tuominen et al., 2002), whereas A-site binding resulted in no
detectable changes in the absorption spectrum.
The C-site is formed by a hydrophobic cavity from the surface of Cytc to the embedded
heme group (Dickerson et al., 1971). Cardiolipin interaction with the C-site results in a
tightly bound configuration, in which one cardiolipin acyl chain is inserted into the
hydrophobic groove while keeping the other chains embedded within the mitochondrial
inner membrane (Tuominen et al., 2002). This interaction essentially tethers Cytc to the
membrane and gives rise to the extended lipid anchorage hypothesis that is supported by
mounting evidence of heme-iron spectral changes (Choi and Swanson, 1995; Spooner and
Watts, 1991; Tuominen et al., 2002; Vincent et al., 1987; Vincent and Levin, 1988). An
alternative hypothesis suggesting interactions of two fatty acyls of cardiolipin with Cytc has
also been suggested (Sinibaldi et al., 2010). The binding results in both partial protein
unfolding and conformational changes of the Met80-heme iron interaction, as well as
spectral changes in the heme iron spin state (Tuominen et al., 2002). These changes could
allow for H2O2 access to the heme environment of Cytc (Choi and Swanson, 1995;
Tuominen et al., 2002) and may account for a peroxide-dependent initiation of Cytc-
catalyzed cardiolipin peroxidation (Kagan et al., 2005).
Prior to the release of Cytc from the mitochondria during apoptosis, a redistribution of
cardiolipin occurs (Garcia Fernandez et al., 2002). The majority of cardiolipin, almost 80%,
is located in the inner mitochondrial membrane and constitutes about 20% of the membrane
lipids found there. In apoptotic cells a membrane translocation occurs that results in almost
40% of the cardiolipin of the inner mitochondrial membrane relocating to the outer-
membrane (Kagan et al., 2006). Here it participates in the formation of Cytc/cardiolipin
peroxidase complexes and – after cardiolipin peroxidation – the formation of the
mitochondrial permeability transition pore, which facilitates release of Cytc and other pro-
apoptotic factors into the cytosol. In addition, there are changes in the molar ratio of
cardiolipin distribution between the two monolayers of the inner-membrane (Kagan et al.,
2006). This redistribution occurs prior to the release of pro-apoptotic factors and other
indicators of apoptosis, but takes place after the generation and accumulation of ROS
(Garcia Fernandez et al., 2002; Gonzalvez and Gottlieb, 2007; Kagan et al., 2005).
The oxidation activity that occurs during apoptosis is specific for cardiolipin and fully
dependent upon Cytc (Kagan et al., 2005). The extent of cardiolipin oxidation and
sensitivity to the apoptosis-inducing agent actinomycin D is directly proportional to the
amount of Cytc present in the cell lines tested (Kagan et al., 2005). Once cardiolipin was
oxidized, the affinity between cardiolipin and Cytc was greatly decreased (Kagan et al.,
2005; Nakagawa, 2004) allowing for cardiolipin redistribution and likely association with
Bcl-2 family proteins at the mitochondrial outer membrane. The decreased affinity between
Cytc and peroxidized cardiolipin also provides a greater abundance of free Cytc within the
intermembrane space. Free Cytc is needed for release into the cytosol followed by caspase
activation. Cytc knockout cells showed no cardiolipin oxidation activity and lacked release
of pro-apoptotic factors, such as Smac/Diablo, when treated with actinomycin D (Kagan et
al., 2005). Interestingly, normal release of these factors can be achieved by addition of
oxidized cardiolipin. Such treatment has also been shown to induce specific release of pro-
apoptotic factors even in the absence of apoptotic stimuli (Kagan et al., 2005). These
findings suggest that the oxidation of cardiolipin fully relies upon Cytc. Subsequently,
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permeabilization of the outer membrane increases, but passage through the membrane is
restricted to apoptotic factors as opposed to non-specific damage of mitochondria.
The cardiolipin-Cytc interaction involved in the oxidation of cardiolipin occurs via the C-
site. This hydrophobic binding pocket is bordered by Phe10 and Tyr97 (Dickerson et al.,
1971). This also puts the binding in close proximity to the embedded heme group of Cytc
which is believed to be involved in the oxidation process and necessary for the transfer of
electrons (Dickerson et al., 1971; Kagan et al., 2005). Activation of peroxidases that
function via a heme group, such as Cytc, typically requires the formation of a protein-bound
radical; in the case of Cytc a tyrosine radical has been identified (Kagan et al., 2005;
Svistunenko, 2005; Tyurina et al., 2006). Tyr97 is in close proximity to the cardiolipin
binding site and can be covalently modified via phosphorylation, thus providing a possible
means of regulating the Cytc-cardiolipin interaction and the formation of the peroxidase
complex. In addition, recent evidence suggests that Tyr67, which is one of four conserved
tyrosines present in Cytc and in closest proximity to the heme group is a likely candidate
involved in the Cytc-driven oxidation of cardiolipin (Kapralov et al., submitted).
The peroxidase activity of Cytc is dependent on the physical interaction between Cytc and
cardiolipin. Solubilized Cytc was shown to have weak peroxidase activity and a barely
detectable electron paramagnetic resonance (EPR) signal for tyrosyl radical formation
(Tyurina et al., 2006). When cardiolipin is bound to Cytc in the presence of H2O2, the heme
group of Cytc reacts to form the highly reactive intermediates, compounds I and II (see
equations 2 and 3 below). Compound I is a short-lived ferrylporphyrin radical formed by the
H2O2 driven oxidation of the heme-iron center (Barr et al., 1996). The heme-iron is
oxidized, with the reduction of H2O2 to water, from a ferric oxidation state to Fe(V), and
compound II is formed via the abstraction of an electron from a tyrosine residue, resulting in
reduction of Fe(V) to Fe(IV) and the formation of a tyrosyl radical (Dunford, 1987; Tyurina
et al., 2006). In the presence of nonoxidizable cardiolipin this tyrosyl radical can dimerize
with other tyrosyl radicals that have been formed (see equation 4 below). Alternatively, in
the presence of oxidizable cardiolipin the tyrosyl radical catalyzes the oxidation of
cardiolipin (Tyurina et al., 2006) resulting in decreased affinity between and dissociation of
cardiolipin and Cytc (Nakagawa, 2004).
Proposed reaction intermediates for Cytc-catalyzed peroxidation of cardiolipin (CL)
(Tyurina et al., 2006):
1. CL + Cytc-[Fe3+ + Tyr] → CL/Cytc-[Fe3+ + Tyr]
2. CL/Cytc-[Fe3+ + Tyr] + H2O2 → CL/Cytc-[Fe5+=O + Tyr] (Compound I) + H2O
3. CL/Cytc-[Fe5+=O + Tyr] → CL/Cytc-[Fe4+=O + Tyr•] (Compound II)
4. 2x Compound II → Cytc-Tyr–Tyr-Cytc (Cytc dimers and oligomers)
5. CL/Cytc-[Fe4+=O + Tyr•]→ CL•/Cytc-[Fe4+=O + Tyr]
6. CL•/Cytc-[Fe4+=O + Tyr] + O2 →→ CL-OO• + Cytc-[Fe4+=O + Tyr]
The tyrosine radical formed in the activation of peroxidases like that of Cytc is readily
detectable by EPR. Studies of Cytc associated with non-oxidizable 1,1‘,2,2‘-tetraoleoyl-
cardiolipin (TOCL), and with readily oxidizable 1,1‘,2,2‘-teralinoleoyl- cardiolipin (TLCL),
demonstrated that both resulted in the formation of tyrosine radicals when treated with H2O2
(Tyurina et al., 2006). In the absence of cardiolipin an EPR signal corresponding to a
tyrosine radical of Cytc was barely detectable, emphasizing the Cytc peroxidation specificity
for cardiolipin. The magnitude of the tyrosine radical EPR signal from the Cytc/TLCL
complex was significantly less than that of Cytc/TOCL. This 30±7% decrease is thought to
be due to quenching of the tyrosine radical by its involvement in the peroxidation of
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cardiolipin (Tyurina et al., 2006). Recently, by mutating each of the four Tyr residues in
Cytc, Kapralov et al., (submitted) identified Tyr67 – the tyrosine residue closest to the heme
moiety – as the major contributor to the peroxidase activity of Cytc-cardiolipin complex.
Since two out of the four conserved tyrosines in Cytc, Tyr48 and Tyr97, are phosphorylated
in vivo, it is possible that they also exert an effect on its peroxidase activity. Although
studies with in vivo phosphorylated Cytc remain to be performed, we have shown for one of
the four tyrosine residues that the phosphomimetic substitution Tyr48Glu decreased Cytc-
cardiolipin binding by about 30% compared to wild-type unphosphorylated Cytc, and that
Cytc peroxidase activity of the Tyr48Glu mutant was cardiolipin-inducible only at high
cardiolipin concentrations, unlike controls. It is possible that the more bulky phosphate
group present in vivo may exert an even more pronounced effect on the peroxidase activity
of Cytc. Since cardiolipin oxidation is required for Cytc release during apoptosis, the Cytc
phosphorylation state may control this rather early step of the death program.
9. To the next level: a proposal for the regulation of mitochondrial energy
and ROS production via phosphorylation of cytochrome c
The fact that Cytc is phosphorylated in vivo, and that four phosphorylation sites have already
been mapped strongly suggests that the multiple functions of Cytc are tightly regulated and
that this regulation is tissue-specific. For Tyr97- and Tyr48-phosphorylated Cytc as well as
Tyr48Glu phosphomimetic mutant Cytc we have shown that the reaction with CcO is
partially inhibited leading to ‘controlled respiration.’ We propose in what follows that this
effect plays an essential role in the prevention of ROS under healthy conditions; in contrast,
during cellular stress Cytc becomes dephosphorylated, ‘controlled respiration’ is lost, and
Cytc can now also function in apoptosis (Fig. 4). Under these conditions of cellular stress,
the mitochondrial membrane potential (ΔΨm) will be affected and needs to be taken into
account in order to understand the consequences of changes in OxPhos activity. This review
focuses on phosphorylation of Cytc but other OxPhos components may be affected in a
similar fashion.
9.1. The mitochondrial membrane potential (ΔΨm) integrates key determinants of cellular
fate and is regulated through phosphorylation of OxPhos components
For a better understanding of the role of ROS production in a physiological context the
mitochondrial membrane potential (ΔΨm) has to be considered. Respiratory control, the
traditional mechanism regulating the activity of the ETC complexes, is thought to operate
via ΔΨm. At high ΔΨm further proton pumping is inhibited, whereas a decrease in ΔΨm
through proton utilization by ATP synthase would in turn allow the ETC to pump protons.
We recently proposed a model as a significant extension of the traditional concept, in which
cell signaling pathways control the activity of the ETC complexes. This in turn controls
ΔΨm, maintaining healthy, low ΔΨm levels between 80-140 mV (Hüttemann et al., 2008).
Such regulation is crucial for higher organisms because ΔΨm is directly related to the
production of ROS (Fig. 4): at ΔΨm>140 mV, ROS production increases exponentially,
whereas mitochondria of resting cells with a low ΔΨm do not produce significant amounts of
ROS (reviewed in Liu, 1999). Studies based on isolated mitochondria or reconstituted CcO
vesicles showed high ΔΨm values of 180-220 mV (e.g., Cossarizza et al., 1996; Nicholls and
Ferguson, 1992; Steverding and Kadenbach, 1991), but they may not represent physiological
conditions because the phosphorylation state was not preserved during mitochondria
isolation (discussed in Hüttemann et al., 2008). Other studies performed under more
physiological conditions reported ΔΨm values from 80-140 mV in perfused rat hearts, intact
cultured fibroblasts, neuroblastoma cells, lymphocytes, embryonic heart cells, and
osteocarcoma cells (Backus et al., 1993; Brand and Felber, 1984; Porteous et al., 1998; Wan
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et al., 1993; Zhang et al., 2001). Thus, the maintenance of physiologically low ΔΨm values
avoids excessive generation of ROS but provides the full capability to produce ATP because
maximal rates of ATP synthesis by ATP synthase occur at physiological ΔΨm values of
100-120 mV (Kaim and Dimroth, 1999).
Under unstressed conditions the OxPhos system does not work at full capacity. However,
since excess capacity is available it has to be good for something. Given the consequences
of high ΔΨm values, i.e., excessive ROS production, one can conclude that a
hyperpolarization of ΔΨm is a trigger for cell death. Likely, excessive calcium release is
involved in stress signaling to the mitochondria. Calcium induces dephosphorylation of most
mitochondrial proteins (Hopper et al., 2006) and is believed to be the most important signal
for mitochondrial activation (Robb-Gaspers et al., 1998). According to our model, cellular
stress results in excessive calcium release leading to dephosphorylation of Cytc allowing
maximal electron transfer rates, followed by increased ΔΨm levels at which ROS production
occurs, which triggers and amplifies apoptosis (Fig. 4). This idea is consistent with various
recent reports showing that ΔΨm increases after induction of apoptosis, initiated by, e.g.,
calcium, Bax, ROS, and ceramides (reviewed in Kadenbach et al., 2004a). Our findings that
phosphorylation of Cytc (and CcO) lead to controlled respiration provide a unifying
mechanism for maintaining optimal mitochondrial membrane potentials under healthy
conditions, avoiding ROS (Lee et al., 2005; Lee et al., 2009; Lee et al., 2006; Samavati et
al., 2008; Yu et al., 2008, Pecina et al., 2010). In contrast, during apoptotic stress, Cytc
dephosphorylation will contribute to the cell death decision in multiple ways: 1) increased
respiration rates, followed by increased ΔΨm and ROS levels, 2) increased cardiolipin
oxidation rates that allow Cytc to dissociate from the inner mitochondrial membrane and
release into the cytosol, and 3) the dephosphorylated form of Cytc is required to form a
functional apoptosome for downstream caspase activation (Fig. 4).
9.2. Neurodegenerative and cardiovascular diseases as possible examples of dysregulated
Cytc function
Multiple neurodegenerative diseases are characterized by loss of specific neuron populations
due to induction of apoptosis. Mitochondrial dysfunction, that leads to release of Cytc into
the cytoplasm and apoptosis, has been demonstrated in acute neurologic trauma such as
stroke (Fujimura et al., 1998; Rabuffetti et al., 2000; Sugawara et al., 1999) and traumatic
brain and spinal cord injury (Li et al., 2000b) as well as chronic diseases such as
Amyotrophic Lateral Sclerosis (ALS; Li et al., 2000c; Rowland and Shneider, 2001),
Huntington's Disease (Martin, 1999; Wang et al., 2003b; Wang et al., 2008), and Parkinson
Disease (Wu et al., 2002). If release of Cytc could be inhibited, apoptosis could be
prevented, slowing the disease progression or limiting neurologic damage after trauma.
Reperfusion of brain tissue following ischemia initiates a cell death cascade exhibiting
hallmarks of our proposed Cytc-centered mechanism including altered mitochondrial Ca2+
homeostasis (Kobayashi et al., 2003; Starkov et al., 2004), Ca2+ dependent
dephosphorylation of mitochondrial proteins (Schuh et al., 2005), excessive ROS generation
(Wang et al., 2005; Yamato et al., 2003), and cardiolipin peroxidation and redistribution
(Kowalczyk et al., 2009), all culminating in release of Cytc from mitochondria and
induction of apoptotic cell death.
Multiple studies have demonstrated that therapeutic intervention at the level of Cytc release
is an effective neuroprotective strategy (Endo et al., 2006; Sanderson et al., 2008), and that
Cytc release is required for apoptosis to occur (Matapurkar and Lazebnik, 2006). For
example, administration of insulin, a hormone we have shown to induce Cytc
phosphorylation in ischemic brain (unpublished data), prevents Cytc release and neuronal
death following brain ischemia (Sanderson et al., 2008). These data suggest a possible
mechanism of neuroprotection where Cytc release can be prevented and apoptosis avoided
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by using substances that regulate the phosphorylation state of Cytc. Interestingly, another
robust neuroprotective therapy, preconditioning, requires p66shc activation and translocation
to the mitochondria to confer neuroprotection (Brown et al., 2010), suggesting that some
ROS are required as a preconditioning signal. Similar patterns of injury progression have
been demonstrated following traumatic injury to the brain (Sullivan et al., 2002) and spinal
cord (Xu et al., 2005), demonstrating a central role of Cytc release in acute neurologic
trauma. Familial ALS, a chronic neurodegenerative disease, is characterized by the presence
of high levels of ROS due to mutations in the radical scavenger superoxide dismutase
(SOD1) (Rosen et al., 1993). Increased ROS levels damage cells, eventually resulting in loss
of specific motor neuron populations through apoptosis. Radical scavengers have been
proven beneficial in ALS transgenic mice models (Gurney et al., 1996) as well as over-
expression of antiapoptotic Bcl-2 protein (Kostic et al., 1997). Minocycline, a second
generation tetracycline, confers neuroprotection in several models of neurodegeneration
including delay of ALS progression in mice (Zhu et al., 2002). More recently
methazolamide has been tested for efficacy in Huntington's disease. In transgenic mice it
delayed the onset of disease and mortality (Wang et al., 2008). The authors concluded that
the mutual neuroprotective effect may be linked to their shared inhibition of Cytc release
from mitochondria. Promising results like these demonstrate the need for determining the
specific function and signaling events that regulate Cytc.
Cardiomyopathy is a major contributor to congestive heart failure and is propagated by
apoptosis of cardiomyocytes. Immunogold labeling and immunoblotting of cardiomyopic
hearts with anti-Cytc and anti-caspase 3 antibodies revealed significant release of Cytc to the
cytoplasm and activation of caspase 3 when compared to normal heart tissue (Narula et al.,
1999). Cardiac ischemia/reperfusion injury follows a similar pathway with sudden
reperfusion causing excessive ROS production that leads to Cytc release and ultimately
apoptosis. Cytc release in cardiomyocytes has been attributed to many mechanisms
including ROS generation, cardiolipin peroxidation, and Ca2+ overload in the mitochondria.
Indeed, compounds that prevent cardiolipin peroxidation like melatonin protect
mitochondria exposed to Ca2+ overload (Petrosillo et al., 2009b) and limit reperfusion injury
in heart (Petrosillo et al., 2009a). Interestingly, hearts from p66shc knockout mice show
decreased ROS generation during reperfusion and improved tissue protection (Carpi et al.,
2009). These studies suggest a role for p66shc induced ROS production and cardiolipin
peroxidation in release of Cytc from the mitochondria and apoptosis induction. Further
studies, in particular the elucidation of the signaling pathways leading to reversible
phosphorylation of Cytc, are necessary to determine the contribution of Cytc
phosphorylation in the regulation of cell death. This knowledge may allow the development
of therapies that target Cytc directly or through cell signaling to prevent stress stimuli from
damaging otherwise functional cell populations. Furthermore, conditions in which increased
apoptotic activity would be beneficial could be targeted, such as cancer. A general problem
of cancer control are adaptive mechanisms that allow cancer cells to evade the apoptotic
pathway, and Cytc (hyper-) phosphorylation or the inability to dephosphorylate Cytc may be
such an underlying mechanism.
10. Conclusion
The involvement of Cytc in several processes crucial for cellular life and death, including
electron transfer, redox-coupled protein import, cardiolipin oxidation, radical scavenging,
and apoptosome formation (Fig. 1), make it a likely target of regulation by post-translational
modifications. To date, of the four phosphorylation sites mapped on Cytc there is convincing
evidence for the regulatory importance of two tyrosine phosphorylations identified in
mammalian heart and liver. The potential role of these phosphorylations to control
respiration rates and thus ΔΨm and the production of ROS, in addition to direct regulation of
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cell-death associated processes such as cardiolipin oxidation and apoptosome formation
open up the exciting possibility for future manipulation of Cytc phosphorylation in
pathologic conditions where decreased or, in contrast, increased apoptotic activity would be
beneficial, such as neurodegenerative diseases and cancer, respectively.
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Figure 1.
Summary of the main functions of cytochrome c. The left side of the figure highlights its
involvement in life-sustaining functions, whereas its involvement in cellular death functions
is shown on the right side.
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Figure 2.
Stereo view of the cytochrome c structure in the conventional orientation. Crystallographic
data from horse Cytc was used (Sanishvili et al., 1995) and processed with the program
Swiss PDB viewer (version 3.7). Residues Thr28, Ser/Thr47, Tyr48, and Tyr97 that can be
phosphorylated in mammals are highlighted in purple (Lee et al., 2006; Yu et al., 2008;
Zhao et al., 2010). A-side residues Lys72, Lys73, and Lys87 (yellow ribbon) and C-side
residue 52 (turquoise ribbon) proposed to be involved in phospho-lipid binding through
electrostatic interaction with the negatively charged lipid head group (Kagan et al., 2009) are
highlighted. Amino acids Glu69, Asn70, and Lys88 indicated in red ribbon form an ATP
binding pocket together with C-side residues Lys72, Lys86, and Lys87 (yellow ribbon)
(McIntosh et al., 1996). Key residues required for Apaf-1 binding and caspase activation are
highlighted in blue sticks. Phosphorylation sites localize to the right side of the molecule
whereas amino acids involved in binding of phospholipids and ATP are on the left side.
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Figure 3. Cytochrome c alignment
Human (NM_018947), mouse somatic (CAA25899) and testis (NP_034119) cytochrome c
show 81% sequence identity with individual comparisons revealing 91% (human-mouse
somatic), 82% (human-mouse testis), and 86% (mouse somatic-mouse testis) conservation.
Thr28, Ser47, Tyr48, and Tyr97 which can be phosphorylated in vivo are indicated with an
arrow. Note that human Cytc contains an additional fifth tyrosine residue, Tyr46, which is
immediately adjacent to the phospho-epitope containing Ser47 and Tyr48. Future work
should explore if this residue is targeted for human-specific regulation of Cytc via
phosphorylation.
Hüttemann et al. Page 26
Mitochondrion. Author manuscript; available in PMC 2012 May 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4. Regulation of mitochondrial respiration, ROS production, and apoptosis through
phosphorylation of cytohrome c
Our model proposes changes in the phosphorylation state of Cytc during cellular stress as a
switch for the execution of the cell death program: Under healthy unstressed conditions Cytc
is phosphorylated leading to partial inhibition of mitochondrial respiration and healthy
mitochondrial membrane potentials ΔΨm in the range of 80-140 mV. These membrane
potentials are ideal and sufficient to drive efficient ATP generation, and importantly, no
significant amounts of ROS are produced. In addition, under healthy conditions Cytc
functions as a ROS scavenger (not shown). Under stressed conditions, including the
presence of apoptotic stimuli and excessive calcium, a phosphatase dephosphorylates Cytc,
which has multiple consequences. First, maximal ETC flux is now possible resulting in
membrane potentials >140 mV. This hyperpolarization triggers excessive ROS production at
complexes I and III due to backup of electrons in the ETC and increased half-lives of the
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semiquinole free radicals. Second, it is the unphosphorylated form of Cytc which catalyzes
the oxidation of cardiolipin, a step which is required to dissociate Cytc from the inner
mitochondrial membrane and thus to release it from the mitochondria during apoptosis.
Cardiolipin oxidation requires ROS (e.g., peroxide equivalents), which are provided by ΔΨm
hyperpolarization-mediated ROS production. Third, p66shc might also contribute to ROS
production through the interaction with unphosphorylated Cytc. Finally, Cytc is released
from the mitochondria, and it is the unphosphorylated form that is required for apoptosome
formation, another safeguard mechanism for regulating this committing step as part of the
death program. There is strong evidence that the other components of the OxPhos system are
also regulated by phosphorylation, but Cytc appears to be the central player due to its dual
active involvement in both respiration and apoptosis.
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